Ireland· IE-PA-PA23429/008/001
Fosfomycin Ascend 3 g granules for oral solution
A fosfomycin product containing fosfomycin trometamol, registered in Ireland by Ascend GmbH. The same ATC class is registered in 17 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Fosfomycin is registered in 17 of 19 countries.
Countries holding a registration under ATC J01XX01 (fosfomycin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Fosfomycin · ATC J01XX01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fosfomycin costs, country by country.
Normalised to the WHO defined daily dose (3 g), the median price runs from $3.86 in Spain to $16.40 in Switzerland — a ×4.2 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fosfomycin · price per daily dose (3 g)
USD · FX 28 Sept 2026
- CH Switzerland$16.40
- ES Spain$3.86
The record
At a glance
HPRA (Ireland)- Active substance
- Fosfomycin trometamol
- Manufacturer
- Ascend GmbH
- Country
- Ireland (IE)
- ATC code
- J01XX01
- ATC class
- Fosfomycin
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA23429/008/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for fosfomycin.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fosfomycin · interactions on record
3 records
- 2 moderate
- 1 minor
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- BalsalazideA07EC04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fosfomycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRAPIDNORMHerbacos Recordati s.r.o., Pardubice
- BelgiumFosfomycin AB 3 gAurobindo
- SwitzerlandFosfolag
- NetherlandsFosfomycine 3 g Focus, granulaat voor drank in sachetFocus Care Pharmaceuticals B.V.
- United StatesFosfomycin TromethaminePrecision Dose, Inc.
- FinlandMonurolZambon Group S.p.A.
- IcelandMonurilZambon SpA*
- NorwayMonurilZAMBON GmbH
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Cystium, Fomicyt
- Belgium · Fomicyt, Fosfomycin Ab
- Bulgaria · Монурал, Фосфосептик
- Czechia · Fomicyt, Rapidnorm
- Germany · Afosfol, Fosfomycin Al
- Denmark · Fosfomycin Infectopharm, Monurol
- Estonia · Fosfomycin Sandoz, Uridoz
- Spain · Fosfocina, Fosfomicina Abamed
- Finland · Fosfomycin Infectopharm, Monuril
- France · Fomicyt I.V., Fosfomycine Adultes Cristers
- United Kingdom (Northern Ireland) · Alexi, Fomicyt
- Greece · Fomicyt, Fosfocin
- Croatia · Fomicyt, Urifos
- Hungary · Afosfol, Fomicyt
- Iceland · Monuril
- Italy · Berny Adulti, Dafocist Adulti
- Lithuania · Fosfomycin Zentiva, Foziflum
- Luxembourg · Monuril
- Latvia · Foziflum, Rebetyn Vigapharma
- Malta · Monuril
- Netherlands · Fomicyt, Fosfomycine 1a Pharma
- Norway · Fosfomycin Infectopharm, Monuril
- Poland · Afastural, Fosfacin
- Portugal · Fosfomicina Generis, Fosfomicina Generis Phar
- Romania · Fomicyt, Fosfomicină Rompharm
- Sweden · Fosfomycin Infectopharm, Monuril
- Slovenia · Cisof
- Slovakia · Fomicyt, Fosfomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe871a7f-996f-412a-9c1d-cab81f3db8f3 GET /v1/drugs/fe871a7f-996f-412a-9c1d-cab81f3db8f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granules for oral solution",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J01XX01"
],
"strength": null,
"pa_number": "PA23429/008/001",
"substances": [
"Fosfomycin trometamol"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "04/04/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about fosfomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.